Ogier and Loeb & Loeb LLP assisted Model Performance Acquisition Corp in its de-SPAC merger with MultiMetaVerse Inc., represented by Paul Hastings LLP. MultiMetaVerse Inc., an...
Model Performance Acquisition Corp’s de-SPAC Merger with MultiMetaVerse Inc.
Orchestra BioMed’s $110 Million Series D Financing
Paul Hastings LLP advised Orchestra BioMed on the deal. Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced the closing of a $110...
Orchestra BioMed’s Collaboration with Medtronic
Paul Hastings LLP advised Orchestra BioMed on the deal. Orchestra BioMed announced a strategic collaboration with Medtronic to develop Orchestra BioMed’s BackBeat Cardiac Neuromodulation Therapy™ (CNT™) as...
Orchestra BioMed’s Merger with Health Sciences Acquisitions Corporation 2
Paul Hastings LLP advised Orchestra BioMed on the deal. Loeb & Loeb LLP served as legal counsel for HSAC2. Latham & Watkins LLP represented the capital...
Cresco Labs’ $2 Billion Acquisition of Columbia Care
Stoic Advisory Inc. and Solidum Capital Advisors are acting as financial advisor to Cresco Labs. A.G.P./Alliance Global Partners provided a fairness opinion to Cresco Labs’ Board...